These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35168828)

  • 21. Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation.
    Yu AH; Duan-Mu YY; Zhang Y; Wang L; Guo Z; Yu YQ; Wang YS; Cheng XG
    Korean J Radiol; 2018; 19(5):923-929. PubMed ID: 30174482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease.
    Kim S; Kwon H; Park JH; Cho B; Kim D; Oh SW; Lee CM; Choi HC
    BMC Gastroenterol; 2012 Jun; 12():69. PubMed ID: 22691278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography.
    Tanaka M; Okada H; Hashimoto Y; Kumagai M; Nishimura H; Oda Y; Fukui M
    Liver Int; 2020 Jan; 40(1):120-130. PubMed ID: 31518481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study.
    Chiyanika C; Wong VW; Wong GL; Chan HL; Hui SCN; Yeung DKW; Chu WCW
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00300. PubMed ID: 33600104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetes.
    Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Mihara M; Yoshimoto T; Ogawa Y
    J Diabetes Investig; 2016 Jul; 7(4):607-14. PubMed ID: 27182043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study.
    VanWagner LB; Terry JG; Chow LS; Alman AC; Kang H; Ingram KH; Shay C; Lewis CE; Bryan RN; Launer LJ; Jeffrey Carr J
    Obesity (Silver Spring); 2017 Mar; 25(3):642-651. PubMed ID: 28169509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity.
    Shi YX; Chen XY; Qiu HN; Jiang WR; Zhang MY; Huang YP; Ji YP; Zhang S; Li CJ; Lin JN
    Scand J Gastroenterol; 2021 Mar; 56(3):312-320. PubMed ID: 33535004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease.
    Hsieh YC; Joo SK; Koo BK; Lin HC; Kim W
    Liver Int; 2021 Mar; 41(3):494-504. PubMed ID: 33164304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
    Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians.
    Lee S; Kim KW; Lee J
    J Clin Transl Hepatol; 2022 Aug; 10(4):595-599. PubMed ID: 36062272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visceral Fat Area Is an Independent Risk Factor for Overweight or Obese Nonalcoholic Fatty Liver Disease in Potential Living Liver Donors.
    Lee S; Kim KW; Lee J; Park T; Koo K; Song GW; Lee SG
    Transplant Proc; 2022 Apr; 54(3):702-705. PubMed ID: 35256204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grading scale of visceral adipose tissue thickness and their relation to the nonalcoholic fatty liver disease.
    Andrade LJ; Melo PR; Paraná R; Daltro C
    Arq Gastroenterol; 2014; 51(2):118-22. PubMed ID: 25003263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat.
    Chen TP; Lin WY; Chiang CH; Shen TH; Huang KC; Yang KC
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2903-2910. PubMed ID: 33973273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.
    Xu C; Ma Z; Wang Y; Liu X; Tao L; Zheng D; Guo X; Yang X
    Liver Int; 2018 Dec; 38(12):2294-2300. PubMed ID: 30099825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.